PAVmed Inc. announced that Lucid Diagnostics' EsoGuard esophageal DNA test is now fully reimbursed by Medicare nationwide, marking a significant commercial milestone. This reimbursement is expected to drive substantial near-term revenue growth, with Lucid already seeing record test volumes. Additionally, Veris Health is advancing its implantable physiological monitor toward FDA submission, and PAVmed is engaging with the FDA on other devices, positioning the company for long-term value creation. Financially, PAVmed reported a non-GAAP adjusted net loss of $1.2 million for Q3 2026, with improved cash reserves compared to the previous year.
PAVmed's recent business update and preliminary Q3 2026 results provide context for health sector performance on Pluang. For readers following health stocks, here is Pluang's market snapshot as of Nov 13, 2026 19:41 WIB: out of 150 priced health-sector US stocks, 99 rose and 43 fell today. Among notable movers, MMED traded at USD 17.00 with a 4.90% decline and a typical hold time of 19 days, CTXR was priced at USD 0.51 down 4.21% with 84% sell order activity, and TNGX closed at USD 24.00, down 3.42% with a shorter hold time of 4 days.
Michelin has announced the total number of its voting rights and shares as of October 31, 2026. The company has 691,516,292 shares and 960,075,649 voting rights, considering 20,287,710 treasury shares. This disclosure complies with French regulations...
Michelin has disclosed the total number of voting rights and shares composing its capital as of October 31, 2026. The company reported 691,516,292 shares, with theoretical voting rights totaling 980,363,359 and exercisable voting rights at 960,075,64...
KeyBanc lowered its price target for YETI Holdings to $49, suggesting a 27.94% upside from the current $38.30 stock price. This follows YETI's reduction of its full-year adjusted sales growth forecast to about 6% from the previous 7-8%, citing consum...
Bernstein SocGen Group has reduced its price target for Applied Materials to $600, even though the company reported higher sales and profits in Q4 2026 driven by strong demand for semiconductor services, especially AI chips. Applied Materials posted ...
Boralex Inc. announced a private placement of $600 million Canadian dollars in green bonds, split into two series maturing in 2031 and 2036 with interest rates of 4.503% and 5.173%, respectively. This marks Boralex's first issuance of green corporate...
